Literature DB >> 30025687

Pressure-Volume Loop Analysis of Multipoint Pacing With a Quadripolar Left Ventricular Lead in Cardiac Resynchronization Therapy.

Wouter M van Everdingen1, Alwin Zweerink2, Odette A E Salden3, Maarten J Cramer3, Pieter A Doevendans3, Elien B Engels4, Albert C van Rossum2, Frits W Prinzen4, Kevin Vernooy5, Cornelis P Allaart2, Mathias Meine3.   

Abstract

OBJECTIVES: This study aimed to compare multipoint pacing (MPP) to optimal biventricular pacing with a quadripolar left ventricular (LV) lead and find factors associated with hemodynamic response to MPP.
BACKGROUND: MPP with a quadripolar LV lead may increase response to cardiac resynchronization therapy.
METHODS: Heart failure patients with a left bundle branch block underwent cardiac resynchronization therapy implantation. Q to LV sensing interval divided by the intrinsic QRS duration was measured. Invasive pressure-volume loops were assessed during 4 biventricular pacing settings and 3 MPP settings, using 4 atrioventricular delays. Hemodynamic response was defined as change in stroke work (Δ%SW) compared with baseline measurements during intrinsic conduction. Δ%SW of MPP was compared with conventional biventricular pacing using the distal electrode and the electrode with highest Δ%SW (BIV-OPT).
RESULTS: Forty-three patients were analyzed (age 66 ± 10 years, 63% men, 30% ischemic cardiomyopathy, LV ejection fraction 29 ± 8%, and QRS duration 175 ± 13 ms). Q to local LV sensing interval corrected for QRS duration was 84 ± 8%, and variation between LV electrodes was 9 ± 5%. Compared with conventional biventricular pacing using the distal electrode, MPP showed a significant higher increase of SW (Δ%SW +15 ± 35%; p < 0.05) with a large interindividual variation. There was no significant difference in Δ%SW with MPP compared with BIV-OPT (-5 ± 24%; p = 0.19). Male sex and low LV ejection fraction were associated with increase in Δ%SW due to MPP versus BIV-OPT in multivariate analysis, while ischemic cardiomyopathy was only associated in univariate analysis.
CONCLUSIONS: Optimization of the pacing site of a quadripolar LV lead is more important than to program MPP. However, specific subgroups (i.e., especially men) may benefit substantially from MPP.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute hemodynamic response; cardiac resynchronization therapy; multipoint pacing; pressure-volume loops; quadripolar lead

Mesh:

Year:  2018        PMID: 30025687     DOI: 10.1016/j.jacep.2018.02.005

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  6 in total

Review 1.  Pressure Volume System for Management of Heart Failure and Valvular Heart Disease.

Authors:  Frederick G P Welt; James C Fang
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

2.  Clinical outcome of left ventricular multipoint pacing versus conventional biventricular pacing in cardiac resynchronization therapy: a systematic review and meta-analysis.

Authors:  Feng Hu; Lihui Zheng; Ligang Ding; Zhongpeng Du; Erpeng Liang; Lingmin Wu; Gang Chen; Xiaohan Fan; Yan Yao; Yu Jiang
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

Review 3.  Cardiac resynchronization therapy in heart failure patients: tough road but clear future.

Authors:  Ziyu Wang; Yongquan Wu; Junmeng Zhang
Journal:  Heart Fail Rev       Date:  2020-10-24       Impact factor: 4.214

Review 4.  Prevention of non-response to cardiac resynchronization therapy: points to remember.

Authors:  Huolan Zhu; Tong Zou; You Zhong; Chenguang Yang; Yirong Ren; Fang Wang
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

Review 5.  Optimal CRT Implantation-Where and How To Place the Left-Ventricular Lead?

Authors:  Christian Butter; Christian Georgi; Martin Stockburger
Journal:  Curr Heart Fail Rep       Date:  2021-09-08

6.  Evaluating multisite pacing strategies in cardiac resynchronization therapy in the preclinical setting.

Authors:  Luuk I B Heckman; Marion Kuiper; Frederic Anselme; Filippo Ziglio; Nicolas Shan; Markus Jung; Stef Zeemering; Kevin Vernooy; Frits W Prinzen
Journal:  Heart Rhythm O2       Date:  2020-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.